Recent legislation creates a different approach to legal cannabis in the state.
On August 8th, 2023 New Hampshire governor Chris Sununu signed into law House Bill 611, which created a commission intending to study cannabis legalization modeled after state-run liquor operations instead of through private businesses (1).
“With us controlling the retail on the marketing and the branding side, we would be able to control all that and we do it really well,” Governor Sununu said (2). “Our New Hampshire liquor stores are ranked one of the top five retailers in the country. So we have a model that works. Other states don’t really have that, and so we can build off of that.”
“So let’s provide it with protection,” Sununu also stated (2). “There’ll be some revenue from it—but you should never be legalizing more drugs for revenue. That has ethical and moral problems wrapped all around it. Other states did that we’re not going down that path. So I think if they can do it, we can get it done.”
The model will be unique to the Granite State (1). Amendments to the bill include removing the requirement that severe pain be treatment-resistant before a patient qualifies for medical cannabis, and prohibits the sale of hemp containing certain amounts of tetrahydrocannabinol (THC) (3).
Earlier this year, the governor vetoed a bill that would have made possession of up to four ounces of cannabis legal, and also issued a statement explaining his preferred path toward legalization in the state (4).
According to the new legislation, the newly formed commission will include five senators and five House representatives, as well as representatives from Attorney General’s Office, the New Hampshire Association of Chiefs of Police, the New Hampshire Bankers Association, the New Hampshire Liquor Commission, the American Civil Liberties Union, the New Hampshire Medical Society, and Communities for Alcohol and Drug-Free Youth (3).
This commission is required to report its findings and recommendations by December of this year (1).
References
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.